Neurocia SAS
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Neurocia SAS operates in Healthcare & Life Sciences and is based in Montlaur. It was founded in 2020.
Neurocia SAS is a medtech company that develops non-invasive radiofrequency neuromodulation devices to treat neurodegenerative disorders such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocia SAS Comparables
Compare Neurocia SAS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| REGEnLIFE | 83% | |
| NeuroEM Therapeutics | 82% | |
| Bottneuro AG | 81% |
For institutional investors. Book with your work email.
Neurocia SAS Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 56% MoM.
- Mar 2, 2026
Monthly visitors increased 72% MoM.
For institutional investors. Book with your work email.
Neurocia SAS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurocia SAS's valuation, stock price, and market status.
Is Neurocia SAS a public or private company?
Neurocia SAS is a private company.
What is the current stock price of Neurocia SAS?
Neurocia SAS is a private company, so its shares have no public market price. Caplight tracks Neurocia SAS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurocia SAS worth (valuation)?
Valuation information for Neurocia SAS is not publicly available.
Can I buy Neurocia SAS stock?
Neurocia SAS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurocia SAS's last funding round?
Funding round information for Neurocia SAS is not publicly available.
Who are the main investors in Neurocia SAS?
Investor information for Neurocia SAS is not publicly disclosed.
Will Neurocia SAS IPO soon?
No public IPO plans have been announced for Neurocia SAS.
How can I track Neurocia SAS secondary market activity?
Caplight tracks bids, offers, and trades in Neurocia SAS's shares on secondary markets.